Linda H. Malkas is currently professor and associate chair of the Department of Molecular and Cellular Biology at the Beckman Research Institute of City of Hope, serving as the deputy director of basic research. In 2011, she co-founded the Molecular Oncology Program at the cancer center. Most recently Dr. Malkas was appointed as a Board Member to the Independent Citizen’s Oversight Committee which serves as trustees of the people of the State of California and are expected to carry out the mandate of the California Institute for Regenerative Medicine to the best of their ability and judgment and in the best interests of the people of California.
Dr. Malkas received her B.A. in chemistry and Ph.D. in biochemistry from the City University of New York. She completed her post-doctoral studies at the Worchester Foundation for Experimental Biology in Massachusetts, and held faculty positions at the University of Maryland School Of Medicine in Baltimore. Before joining City of Hope, she was at the Indiana University School of Medicine as a Professor of Medicine and the University’s first Vera Bradley Chair in Oncology. While there, she co-founded and served as co-leader of the Indiana University Simon Cancer Center’s Breast Cancer Research Program. She also founded and served as the first Director of the Signature Center for Breast Cancer Research at Indiana University.
Dr. Malkas has published more than 75 peer-reviewed publications in respected journals, given many plenary and platform presentations at national and international scientific meetings, and participated in a variety of NIH and DOD grant review study sections. Dr. Malkas is also a member of the Editorial Boards for Cancer Research, Cancer Prevention Research, Current Cancer Therapy Reviews, and the American Journal of Translational Research. Since 2011 she has served on the DOD Ovarian Cancer Research Program Integration Panel. She is also an external advisor for Yale University, the University of Texas San Antonio Cancer Centers, the University of Arizona and the University of Wisconsin- Madison. In addition, Dr. Malkas is the co-inventor on more than 23 U.S. and international patents and has received multiple awards and recognitions during her career.
Dr. Malkas’ major research focus is the relationship between DNA replication and cancer. Her laboratory’s recent work has led to the opportunity to develop truly selective, therapeutic agents that will inhibit proteins uniquely expressed by cancer cells.